Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
16.09B
Market cap16.09B
Price-Earnings ratio
21.51
Price-Earnings ratio21.51
Dividend yield
1.16%
Dividend yield1.16%
Average volume
3.51M
Average volume3.51M
High today
$84.49
High today$84.49
Low today
$82.56
Low today$82.56
Open price
$83.99
Open price$83.99
Volume
2.33M
Volume2.33M
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.83
52 Week low$79.83

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $84.47, with a market capitalization of 16.09B. The stock trades at a price-to-earnings (P/E) ratio of 21.51 and offers a dividend yield of 1.2%.

On 2026-05-07, Zimmer Biomet(ZBH) stock moved within a range of $82.56 to $84.49. With shares now at $84.47, the stock is trading +2.3% above its intraday low and -0.0% below the session's peak.

Trading activity shows a volume of 2.33M, compared to an average daily volume of 3.51M.

The stock's 52-week range extends from a low of $79.83 to a high of $108.29.

The stock's 52-week range extends from a low of $79.83 to a high of $108.29.

ZBH News

Simply Wall St 4d
Zimmer Biomet Is Down 9.2% After Strong Q1, CFO Exit And Ongoing Buybacks – Has The Bull Case Changed?

In late April 2026, Zimmer Biomet Holdings reported first-quarter 2026 results showing sales of US$2,086.7 million and net income of US$238.1 million, reaffirme...

Zimmer Biomet Is Down 9.2% After Strong Q1, CFO Exit And Ongoing Buybacks – Has The Bull Case Changed?

Analyst ratings

61%

of 31 ratings
Buy
29%
Hold
61.3%
Sell
9.7%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.